GNL In the News

Dr. Gary Kobinger to join GNL as new Director

Jun 15, 2021, 12:45 PM by Connie Holubar

June 15, 2021

The University of Texas Medical Branch has announced the results of an international search for a new Director of the Galveston National Laboratory.  Gary Kobinger, PhD, OM, MSC, will join the institution on Sept. 1, 2021.

 Dr. Kobinger earned his PhD from the University of Montreal and completed a post-doctoral fellowship at the University of Pennsylvania. In 2005, he was recruited by the Public Health Agency of Canada, and from 2008 to 2016 he served as Chief of the Special Pathogens Biosafety Level 4 program at the National Microbiology Laboratory.  

 Since 2016, Dr. Kobinger has been Director of the Centre de Recherche en Infectiologie (Infectious Diseases Research Center) at Université Laval in Québec, Canada, where he has also served as Professor in the Department of Infectious Diseases, Microbiology and Immunology. He concurrently held appointments of associate professor at the University of Manitoba and adjunct professor at the University of Pennsylvania.

 His many honors include the Meritorious Service Cross (civil division) of the Governor General of Canada, the Ernest C. Manning Principal Award, and the Governor General of Canada’s Innovation Award. Dr. Kobinger was elected by the World Health Organization (WHO) to co-chair the Emerging and Dangerous Pathogens Laboratory Global Network for Outbreak Response and Readiness (2008 to 2014), and to serve the International Health Regulation on the roster of experts in Viral Hemorrhagic Fever. He has been an ad hoc advisor to the SAGE committee at WHO, the High Priority Pathogens committee, and is a current advisor to the WHO Deputy Director-General, Emergency Preparedness and Response.

 Dr. Kobinger’s work focuses on developing and testing new vaccine platforms and immune treatments against pathogens of high consequences to global public health. He has co-authored more than 300 peer-reviewed scientific manuscripts and given invited seminars at universities, national and international funding agencies, departments of national defenses, the White House, and the WHO. He has current funding from several agencies, including the National Institutes of Health and Canadian Institutes of Health Research.